Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4301155 | 0.98 | THRB (0.44) | THRB | |
| SCHEMBL7941775 | 0.91 | THRB (0.41) | THRB | |
| SCHEMBL7947965 | 0.81 | THRB (0.33) | THRB | |
| SCHEMBL1836166 | 0.80 | THRB (0.38) | THRB | |
| SCHEMBL18979301 | 0.80 | THRB (0.38) | THRB | |
| SCHEMBL16418239 | 0.73 | LMNA (0.38) | THRB | |
| SCHEMBL3056072 | 0.73 | LMNA (0.38) | THRB | |
| SCHEMBL11402685 | 0.73 | THRB (0.46) | THRB | |
| SCHEMBL6005211 | 0.72 | THRB (0.46) | THRB | |
| SCHEMBL11618473 | 0.72 | THRB (0.71) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117783362-A | Method for detecting content of perfluoro and polyfluoro compound | 中国计量科学研究院 | 2024-03-29 | — | — | CN | claimed |
| CN-117783362-A | Method for detecting content of perfluoro and polyfluoro compound | 中国计量科学研究院 | 2024-03-29 | — | — | CN | disclosed |
| US-11918645-B2 | Vaccines against hepatitis B virus | ALTIMMUNE UK LIMITED (GB) | 2024-03-05 | — | — | US | disclosed |
| US-20240042007-A1 | Fluorocarbon-Linked Peptide Formulation | ALTIMMUNE UK LTD (GB) | 2024-02-08 | — | — | US | disclosed |
| US-11648305-B2 | Fluorocarbon-linked peptide formulation | Altimmune UK Ltd. (GB) | 2023-05-16 | — | — | US | disclosed |
| US-20230090379-A1 | VACCINES AGAINST HEPATITIS B VIRUS | ALTIMMUNE UK LIMITED (GB) | 2023-03-23 | — | — | US | disclosed |
| US-11382969-B2 | Vaccines against Hepatitis B virus | ALTIMMUNE UK LTD (GB) | 2022-07-12 | — | — | US | disclosed |
| EP-3995146-A1 | VACCINES AGAINST HEPATITIS B VIRUS | ALTIMMUNE UK LIMITED (GB) | 2022-05-11 | — | — | EP | disclosed |
| CN-110799559-B | Resin, resin composition, nonwoven fabric, fiber product, separator, secondary battery, electric double layer capacitor, and method for producing nonwoven fabric | 东丽株式会社 | 2022-04-29 | — | — | CN | disclosed |
| US-20220073446-A1 | Antigen Delivery Vectors and Constructs | ALTIMMUNE UK LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |
| US-8110540-B2 | Antigen delivery vectors and constructs | IMMUNE TARGETING SYSTEMS LTD. (GB) | 2012-02-07 | — | — | US | disclosed |
| EP-2374477-A1 | Antigen delivery vectors and constructs | Immune Targeting Systems (GB) | 2011-10-12 | — | — | EP | disclosed |
| US-20100183708-A1 | Antigen Delivery Vectors and Constructs | IMMUNE TARGETING SYSTEMS LTD. | 2010-07-22 | — | — | US | disclosed |
| US-20100183650-A1 | Antigen Delivery Vectors and Constructs | IMMUNE TARGETING SYSTEMS LTD. | 2010-07-22 | — | — | US | disclosed |
| US-7687455-B2 | comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy | IMMUNE TARGETING SYSTEMS LTD. (GB) | 2010-03-30 | — | — | US | disclosed |
| US-20090191233-A1 | INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | IMMUNE TARGETING SYSTEMS LTD. | 2009-07-30 | — | — | US | disclosed |
| EP-1740207-A2 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | Immune Targeting Systems (GB) | 2007-01-10 | — | — | EP | disclosed |
| US-20060013820-A1 | comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy | ALTIMMUNE UK LIMITED (GB) | 2006-01-19 | — | — | US | disclosed |
| WO-2005099752-A9 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | IMMUNE TARGETING SYSTEMS (GB) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005099752-A2 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | IMMUNE TARGETING SYSTEMS (GB) | 2005-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100183650-A1 | Antigen Delivery Vectors and Constructs | LY96, CD74, CD69 | THRB 4280/4885 |
| US-20230090379-A1 | VACCINES AGAINST HEPATITIS B VIRUS | HLA-DRB1, CD4, HLA-B | THRB 457/4885 |
| US-11918645-B2 | Vaccines against hepatitis B virus | HLA-DRB1, CD4, HLA-B | THRB 457/4885 |
| US-20090191233-A1 | INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | LY96, CD74, HAVCR2 | THRB 3929/4885 |
| US-20100183708-A1 | Antigen Delivery Vectors and Constructs | LY96, CD74, CD69 | THRB 4280/4885 |
| US-20220073446-A1 | Antigen Delivery Vectors and Constructs | LY96, CD74, CD69 | THRB 4280/4885 |
| US-11382969-B2 | Vaccines against Hepatitis B virus | CD4, HLA-DRB1, HLA-B | THRB 425/4885 |
| US-20240042007-A1 | Fluorocarbon-Linked Peptide Formulation | VIP, FGB, LNPEP | THRB 3856/4885 |
| US-11648305-B2 | Fluorocarbon-linked peptide formulation | VIP, FGB, LNPEP | THRB 3856/4885 |
| US-20060013820-A1 | comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy | LY96, CD74, HAVCR2 | THRB 4469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.